NEWS
Doctors head for exit at PE-backed IVF player Genea
MELBOURNE: Liverpool Partners’ IVF provider Genea has lost four of its key fertility ... read more
Mesoblast surges on FDA nod for its cell therapy
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per ... read more